141st APHA Annual Meeting

In This section

290419
Expanding access to postabortion care in Rwanda: A pilot project integrating misoprostol into the national comprehensive postabortion care program

Monday, November 4, 2013

Nuriye Nalan Sahin Hodoglugil, MD, MA, DrPH , Venture Strategies Innovations, Berkeley, CA
Fidele Ngabo , Ministry of Health of Rwanda, Kigali, Rwanda
Felix Sayinzoga, MD , Ministry of Health, Rwanda
Eugene Kanyamanza, MD , Ministry of Health, Rwanda
Evangeline Dushimeyezu
John Muganda, MD , Division of Obstetrics and Gynecology, King Faisal Hospital, Kigali, Rwanda
Joanna Ortega, MPH , Venture Strategies Innovations, Berkeley, CA
Calandra Park, MSW
Martine Holston, MPH , VSI: Venture Strategies Innovations, Berkeley, CA
Emma Nesper Holm, MA
Background: Unsafe abortion contributes to almost a fifth of maternal deaths in East Africa. In Rwanda, more than 16,700 women received care for abortion complications in 2009, just two-thirds of those needing treatment. In 2011, the Rwanda Ministry of Health (MOH) launched a comprehensive postabortion care (PAC) pilot integrating misoprostol for treatment of incomplete abortion and miscarriage (IAM) and strengthening all components of PAC, to inform national scale-up. Methods: 146 providers were trained in PAC and data collection from all 55 public hospitals and health centers in four pilot districts (Bugesera, Kicukiro, Nyabihu and Gisagara). The MOH developed a PAC protocol to standardize service delivery. Data were collected between February and October 2012 from the pilot's PAC registers. Results: 921 women were treated for IAM during the pilot, 408 (44.3%) at hospitals and 513 (55.7%) at health centers. Nurses (66.9%) and doctors (33.1%) provided most services. Misoprostol was used to treat 83.4% of all women in health centers and hospitals, compared to oxytocin (13.1%), manual vacuum aspiration (0.4%), and dilatation and curettage (3.0%). At pilot's end, the 50 health centers were treating 91.1% of women presenting with IAM; whereas at baseline, only two health centers provided PAC. Thus, referrals from health centers to hospitals reduced to 8.9%. Postabortion contraception uptake varied between districts from 34.6% to 84.1%. Conclusion: Rwanda's PAC pilot enabled nurses to provide PAC, including treatment with misoprostol, which was not previously possible. Expansion of PAC services is expected to increase women's access and reduce health system costs.

Learning Areas:
Implementation of health education strategies, interventions and programs
Public health or related public policy

Learning Objectives:
Describe findings from a pilot project testing the feasibility of integrating misoprostol into the national comprehensive postabortion care program in Rwanda. Discuss lessons learned from the pilot program which can inform national scale-up.

Keywords: Post-Abortion Care, International Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a public health physician with many years of experience in women’s reproductive health. I have lead research and programs in the areas of family planning, sexually transmitted diseases, HIV prevention, prevention maternal mortality. Currently I am the Associate Medical Director of VSI (Venture Strategies Innovations), an international women’s health NGO committed to improving women’s health by creating access to effective and affordable technologies on a large scale.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.